Global Paclitaxel Injection (Albumin-bound) Supply, Demand and Key Producers, 2023-2029

Global Paclitaxel Injection (Albumin-bound) Supply, Demand and Key Producers, 2023-2029

Page: 100

Published Date: 11 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

The global Paclitaxel Injection (Albumin-bound) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Paclitaxel Injection (Albumin-bound) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Paclitaxel Injection (Albumin-bound), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paclitaxel Injection (Albumin-bound) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Paclitaxel Injection (Albumin-bound) total production and demand, 2018-2029, (K Units)
Global Paclitaxel Injection (Albumin-bound) total production value, 2018-2029, (USD Million)
Global Paclitaxel Injection (Albumin-bound) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paclitaxel Injection (Albumin-bound) domestic production, consumption, key domestic manufacturers and share
Global Paclitaxel Injection (Albumin-bound) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Paclitaxel Injection (Albumin-bound) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luye Pharma Group, CSPC Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals, Celgene, Teva, Qilu Pharmaceutical (Hainan) and Zhejiang Hisun Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paclitaxel Injection (Albumin-bound) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Paclitaxel Injection (Albumin-bound) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Paclitaxel Injection (Albumin-bound) Market, Segmentation by Type
Original Drug
Generic Drug

Global Paclitaxel Injection (Albumin-bound) Market, Segmentation by Application
Lung Cancer
Breast Cancer
Pancreatic Cancer
Other

Companies Profiled:
Luye Pharma Group
CSPC Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals
Celgene
Teva
Qilu Pharmaceutical (Hainan)
Zhejiang Hisun Pharmaceutical

Key Questions Answered
1. How big is the global Paclitaxel Injection (Albumin-bound) market?
2. What is the demand of the global Paclitaxel Injection (Albumin-bound) market?
3. What is the year over year growth of the global Paclitaxel Injection (Albumin-bound) market?
4. What is the production and production value of the global Paclitaxel Injection (Albumin-bound) market?
5. Who are the key producers in the global Paclitaxel Injection (Albumin-bound) market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Paclitaxel Injection (Albumin-bound) Introduction
1.2 World Paclitaxel Injection (Albumin-bound) Supply & Forecast
1.2.1 World Paclitaxel Injection (Albumin-bound) Production Value (2018 & 2022 & 2029)
1.2.2 World Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.2.3 World Paclitaxel Injection (Albumin-bound) Pricing Trends (2018-2029)
1.3 World Paclitaxel Injection (Albumin-bound) Production by Region (Based on Production Site)
1.3.1 World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018-2029)
1.3.2 World Paclitaxel Injection (Albumin-bound) Production by Region (2018-2029)
1.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Region (2018-2029)
1.3.4 North America Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.5 Europe Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.6 China Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.7 Japan Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paclitaxel Injection (Albumin-bound) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paclitaxel Injection (Albumin-bound) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Paclitaxel Injection (Albumin-bound) Demand (2018-2029)
2.2 World Paclitaxel Injection (Albumin-bound) Consumption by Region
2.2.1 World Paclitaxel Injection (Albumin-bound) Consumption by Region (2018-2023)
2.2.2 World Paclitaxel Injection (Albumin-bound) Consumption Forecast by Region (2024-2029)
2.3 United States Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.4 China Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.5 Europe Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.6 Japan Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.7 South Korea Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.8 ASEAN Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.9 India Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)

3 World Paclitaxel Injection (Albumin-bound) Manufacturers Competitive Analysis
3.1 World Paclitaxel Injection (Albumin-bound) Production Value by Manufacturer (2018-2023)
3.2 World Paclitaxel Injection (Albumin-bound) Production by Manufacturer (2018-2023)
3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Manufacturer (2018-2023)
3.4 Paclitaxel Injection (Albumin-bound) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paclitaxel Injection (Albumin-bound) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paclitaxel Injection (Albumin-bound) in 2022
3.5.3 Global Concentration Ratios (CR8) for Paclitaxel Injection (Albumin-bound) in 2022
3.6 Paclitaxel Injection (Albumin-bound) Market: Overall Company Footprint Analysis
3.6.1 Paclitaxel Injection (Albumin-bound) Market: Region Footprint
3.6.2 Paclitaxel Injection (Albumin-bound) Market: Company Product Type Footprint
3.6.3 Paclitaxel Injection (Albumin-bound) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Comparison
4.1.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Comparison
4.2.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Comparison
4.3.1 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)
4.5 China Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share
4.5.1 China Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.5.3 China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)
4.6 Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)

5 Market Analysis by Type
5.1 World Paclitaxel Injection (Albumin-bound) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Original Drug
5.2.2 Generic Drug
5.3 Market Segment by Type
5.3.1 World Paclitaxel Injection (Albumin-bound) Production by Type (2018-2029)
5.3.2 World Paclitaxel Injection (Albumin-bound) Production Value by Type (2018-2029)
5.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Paclitaxel Injection (Albumin-bound) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Pancreatic Cancer
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Paclitaxel Injection (Albumin-bound) Production by Application (2018-2029)
6.3.2 World Paclitaxel Injection (Albumin-bound) Production Value by Application (2018-2029)
6.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2029)

7 Company Profiles
7.1 Luye Pharma Group
7.1.1 Luye Pharma Group Details
7.1.2 Luye Pharma Group Major Business
7.1.3 Luye Pharma Group Paclitaxel Injection (Albumin-bound) Product and Services
7.1.4 Luye Pharma Group Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Luye Pharma Group Recent Developments/Updates
7.1.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.2 CSPC Pharmaceutical Group
7.2.1 CSPC Pharmaceutical Group Details
7.2.2 CSPC Pharmaceutical Group Major Business
7.2.3 CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Product and Services
7.2.4 CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSPC Pharmaceutical Group Recent Developments/Updates
7.2.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
7.3 Jiangsu Hengrui Pharmaceuticals
7.3.1 Jiangsu Hengrui Pharmaceuticals Details
7.3.2 Jiangsu Hengrui Pharmaceuticals Major Business
7.3.3 Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Product and Services
7.3.4 Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
7.3.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Celgene
7.4.1 Celgene Details
7.4.2 Celgene Major Business
7.4.3 Celgene Paclitaxel Injection (Albumin-bound) Product and Services
7.4.4 Celgene Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Celgene Recent Developments/Updates
7.4.6 Celgene Competitive Strengths & Weaknesses
7.5 Teva
7.5.1 Teva Details
7.5.2 Teva Major Business
7.5.3 Teva Paclitaxel Injection (Albumin-bound) Product and Services
7.5.4 Teva Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Recent Developments/Updates
7.5.6 Teva Competitive Strengths & Weaknesses
7.6 Qilu Pharmaceutical (Hainan)
7.6.1 Qilu Pharmaceutical (Hainan) Details
7.6.2 Qilu Pharmaceutical (Hainan) Major Business
7.6.3 Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Product and Services
7.6.4 Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Qilu Pharmaceutical (Hainan) Recent Developments/Updates
7.6.6 Qilu Pharmaceutical (Hainan) Competitive Strengths & Weaknesses
7.7 Zhejiang Hisun Pharmaceutical
7.7.1 Zhejiang Hisun Pharmaceutical Details
7.7.2 Zhejiang Hisun Pharmaceutical Major Business
7.7.3 Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Product and Services
7.7.4 Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.7.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Paclitaxel Injection (Albumin-bound) Industry Chain
8.2 Paclitaxel Injection (Albumin-bound) Upstream Analysis
8.2.1 Paclitaxel Injection (Albumin-bound) Core Raw Materials
8.2.2 Main Manufacturers of Paclitaxel Injection (Albumin-bound) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paclitaxel Injection (Albumin-bound) Production Mode
8.6 Paclitaxel Injection (Albumin-bound) Procurement Model
8.7 Paclitaxel Injection (Albumin-bound) Industry Sales Model and Sales Channels
8.7.1 Paclitaxel Injection (Albumin-bound) Sales Model
8.7.2 Paclitaxel Injection (Albumin-bound) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2018-2023)
Table 5. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2024-2029)
Table 6. World Paclitaxel Injection (Albumin-bound) Production by Region (2018-2023) & (K Units)
Table 7. World Paclitaxel Injection (Albumin-bound) Production by Region (2024-2029) & (K Units)
Table 8. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2018-2023)
Table 9. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2024-2029)
Table 10. World Paclitaxel Injection (Albumin-bound) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paclitaxel Injection (Albumin-bound) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paclitaxel Injection (Albumin-bound) Major Market Trends
Table 13. World Paclitaxel Injection (Albumin-bound) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paclitaxel Injection (Albumin-bound) Consumption by Region (2018-2023) & (K Units)
Table 15. World Paclitaxel Injection (Albumin-bound) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paclitaxel Injection (Albumin-bound) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paclitaxel Injection (Albumin-bound) Producers in 2022
Table 18. World Paclitaxel Injection (Albumin-bound) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paclitaxel Injection (Albumin-bound) Producers in 2022
Table 20. World Paclitaxel Injection (Albumin-bound) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paclitaxel Injection (Albumin-bound) Company Evaluation Quadrant
Table 22. World Paclitaxel Injection (Albumin-bound) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paclitaxel Injection (Albumin-bound) Production Site of Key Manufacturer
Table 24. Paclitaxel Injection (Albumin-bound) Market: Company Product Type Footprint
Table 25. Paclitaxel Injection (Albumin-bound) Market: Company Product Application Footprint
Table 26. Paclitaxel Injection (Albumin-bound) Competitive Factors
Table 27. Paclitaxel Injection (Albumin-bound) New Entrant and Capacity Expansion Plans
Table 28. Paclitaxel Injection (Albumin-bound) Mergers & Acquisitions Activity
Table 29. United States VS China Paclitaxel Injection (Albumin-bound) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paclitaxel Injection (Albumin-bound) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paclitaxel Injection (Albumin-bound) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 37. China Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 42. Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 47. World Paclitaxel Injection (Albumin-bound) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paclitaxel Injection (Albumin-bound) Production by Type (2018-2023) & (K Units)
Table 49. World Paclitaxel Injection (Albumin-bound) Production by Type (2024-2029) & (K Units)
Table 50. World Paclitaxel Injection (Albumin-bound) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paclitaxel Injection (Albumin-bound) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paclitaxel Injection (Albumin-bound) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paclitaxel Injection (Albumin-bound) Production by Application (2018-2023) & (K Units)
Table 56. World Paclitaxel Injection (Albumin-bound) Production by Application (2024-2029) & (K Units)
Table 57. World Paclitaxel Injection (Albumin-bound) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paclitaxel Injection (Albumin-bound) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 62. Luye Pharma Group Major Business
Table 63. Luye Pharma Group Paclitaxel Injection (Albumin-bound) Product and Services
Table 64. Luye Pharma Group Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Luye Pharma Group Recent Developments/Updates
Table 66. Luye Pharma Group Competitive Strengths & Weaknesses
Table 67. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 68. CSPC Pharmaceutical Group Major Business
Table 69. CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Product and Services
Table 70. CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSPC Pharmaceutical Group Recent Developments/Updates
Table 72. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 73. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Hengrui Pharmaceuticals Major Business
Table 75. Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Product and Services
Table 76. Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 78. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Celgene Basic Information, Manufacturing Base and Competitors
Table 80. Celgene Major Business
Table 81. Celgene Paclitaxel Injection (Albumin-bound) Product and Services
Table 82. Celgene Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Celgene Recent Developments/Updates
Table 84. Celgene Competitive Strengths & Weaknesses
Table 85. Teva Basic Information, Manufacturing Base and Competitors
Table 86. Teva Major Business
Table 87. Teva Paclitaxel Injection (Albumin-bound) Product and Services
Table 88. Teva Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Teva Recent Developments/Updates
Table 90. Teva Competitive Strengths & Weaknesses
Table 91. Qilu Pharmaceutical (Hainan) Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Pharmaceutical (Hainan) Major Business
Table 93. Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Product and Services
Table 94. Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Qilu Pharmaceutical (Hainan) Recent Developments/Updates
Table 96. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 97. Zhejiang Hisun Pharmaceutical Major Business
Table 98. Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Product and Services
Table 99. Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Paclitaxel Injection (Albumin-bound) Upstream (Raw Materials)
Table 101. Paclitaxel Injection (Albumin-bound) Typical Customers
Table 102. Paclitaxel Injection (Albumin-bound) Typical Distributors
List of Figure
Figure 1. Paclitaxel Injection (Albumin-bound) Picture
Figure 2. World Paclitaxel Injection (Albumin-bound) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paclitaxel Injection (Albumin-bound) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 5. World Paclitaxel Injection (Albumin-bound) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2018-2029)
Figure 7. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2018-2029)
Figure 8. North America Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 9. Europe Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 10. China Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 11. Japan Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 12. Paclitaxel Injection (Albumin-bound) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 15. World Paclitaxel Injection (Albumin-bound) Consumption Market Share by Region (2018-2029)
Figure 16. United States Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 17. China Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 18. Europe Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 19. Japan Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 22. India Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paclitaxel Injection (Albumin-bound) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paclitaxel Injection (Albumin-bound) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paclitaxel Injection (Albumin-bound) Markets in 2022
Figure 26. United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paclitaxel Injection (Albumin-bound) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 30. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 32. World Paclitaxel Injection (Albumin-bound) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Type in 2022
Figure 34. Original Drug
Figure 35. Generic Drug
Figure 36. World Paclitaxel Injection (Albumin-bound) Production Market Share by Type (2018-2029)
Figure 37. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Type (2018-2029)
Figure 38. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Paclitaxel Injection (Albumin-bound) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Application in 2022
Figure 41. Lung Cancer
Figure 42. Breast Cancer
Figure 43. Pancreatic Cancer
Figure 44. Other
Figure 45. World Paclitaxel Injection (Albumin-bound) Production Market Share by Application (2018-2029)
Figure 46. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Application (2018-2029)
Figure 47. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paclitaxel Injection (Albumin-bound) Industry Chain
Figure 49. Paclitaxel Injection (Albumin-bound) Procurement Model
Figure 50. Paclitaxel Injection (Albumin-bound) Sales Model
Figure 51. Paclitaxel Injection (Albumin-bound) Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Paclitaxel Injection (Albumin-bound) Supply, Demand and Key Producers, 2023-2029

Global Paclitaxel Injection (Albumin-bound) Supply, Demand and Key Producers, 2023-2029

Page: 100

Published Date: 11 Feb 2023

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

The global Paclitaxel Injection (Albumin-bound) market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Paclitaxel Injection (Albumin-bound) production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Paclitaxel Injection (Albumin-bound), and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Paclitaxel Injection (Albumin-bound) that contribute to its increasing demand across many markets.

Highlights and key features of the study
Global Paclitaxel Injection (Albumin-bound) total production and demand, 2018-2029, (K Units)
Global Paclitaxel Injection (Albumin-bound) total production value, 2018-2029, (USD Million)
Global Paclitaxel Injection (Albumin-bound) production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Paclitaxel Injection (Albumin-bound) domestic production, consumption, key domestic manufacturers and share
Global Paclitaxel Injection (Albumin-bound) production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Paclitaxel Injection (Albumin-bound) production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Paclitaxel Injection (Albumin-bound) market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Luye Pharma Group, CSPC Pharmaceutical Group, Jiangsu Hengrui Pharmaceuticals, Celgene, Teva, Qilu Pharmaceutical (Hainan) and Zhejiang Hisun Pharmaceutical, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Paclitaxel Injection (Albumin-bound) market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Paclitaxel Injection (Albumin-bound) Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global Paclitaxel Injection (Albumin-bound) Market, Segmentation by Type
Original Drug
Generic Drug

Global Paclitaxel Injection (Albumin-bound) Market, Segmentation by Application
Lung Cancer
Breast Cancer
Pancreatic Cancer
Other

Companies Profiled:
Luye Pharma Group
CSPC Pharmaceutical Group
Jiangsu Hengrui Pharmaceuticals
Celgene
Teva
Qilu Pharmaceutical (Hainan)
Zhejiang Hisun Pharmaceutical

Key Questions Answered
1. How big is the global Paclitaxel Injection (Albumin-bound) market?
2. What is the demand of the global Paclitaxel Injection (Albumin-bound) market?
3. What is the year over year growth of the global Paclitaxel Injection (Albumin-bound) market?
4. What is the production and production value of the global Paclitaxel Injection (Albumin-bound) market?
5. Who are the key producers in the global Paclitaxel Injection (Albumin-bound) market?
6. What are the growth factors driving the market demand?
btl

Table of Contents

1 Supply Summary
1.1 Paclitaxel Injection (Albumin-bound) Introduction
1.2 World Paclitaxel Injection (Albumin-bound) Supply & Forecast
1.2.1 World Paclitaxel Injection (Albumin-bound) Production Value (2018 & 2022 & 2029)
1.2.2 World Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.2.3 World Paclitaxel Injection (Albumin-bound) Pricing Trends (2018-2029)
1.3 World Paclitaxel Injection (Albumin-bound) Production by Region (Based on Production Site)
1.3.1 World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018-2029)
1.3.2 World Paclitaxel Injection (Albumin-bound) Production by Region (2018-2029)
1.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Region (2018-2029)
1.3.4 North America Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.5 Europe Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.6 China Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.3.7 Japan Paclitaxel Injection (Albumin-bound) Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Paclitaxel Injection (Albumin-bound) Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Paclitaxel Injection (Albumin-bound) Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War

2 Demand Summary
2.1 World Paclitaxel Injection (Albumin-bound) Demand (2018-2029)
2.2 World Paclitaxel Injection (Albumin-bound) Consumption by Region
2.2.1 World Paclitaxel Injection (Albumin-bound) Consumption by Region (2018-2023)
2.2.2 World Paclitaxel Injection (Albumin-bound) Consumption Forecast by Region (2024-2029)
2.3 United States Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.4 China Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.5 Europe Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.6 Japan Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.7 South Korea Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.8 ASEAN Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)
2.9 India Paclitaxel Injection (Albumin-bound) Consumption (2018-2029)

3 World Paclitaxel Injection (Albumin-bound) Manufacturers Competitive Analysis
3.1 World Paclitaxel Injection (Albumin-bound) Production Value by Manufacturer (2018-2023)
3.2 World Paclitaxel Injection (Albumin-bound) Production by Manufacturer (2018-2023)
3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Manufacturer (2018-2023)
3.4 Paclitaxel Injection (Albumin-bound) Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Paclitaxel Injection (Albumin-bound) Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Paclitaxel Injection (Albumin-bound) in 2022
3.5.3 Global Concentration Ratios (CR8) for Paclitaxel Injection (Albumin-bound) in 2022
3.6 Paclitaxel Injection (Albumin-bound) Market: Overall Company Footprint Analysis
3.6.1 Paclitaxel Injection (Albumin-bound) Market: Region Footprint
3.6.2 Paclitaxel Injection (Albumin-bound) Market: Company Product Type Footprint
3.6.3 Paclitaxel Injection (Albumin-bound) Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 United States VS China VS Rest of the World
4.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Comparison
4.1.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Comparison
4.2.1 United States VS China: Paclitaxel Injection (Albumin-bound) Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Paclitaxel Injection (Albumin-bound) Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Comparison
4.3.1 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.4.3 United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)
4.5 China Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share
4.5.1 China Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.5.3 China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)
4.6 Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023)

5 Market Analysis by Type
5.1 World Paclitaxel Injection (Albumin-bound) Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Original Drug
5.2.2 Generic Drug
5.3 Market Segment by Type
5.3.1 World Paclitaxel Injection (Albumin-bound) Production by Type (2018-2029)
5.3.2 World Paclitaxel Injection (Albumin-bound) Production Value by Type (2018-2029)
5.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2029)

6 Market Analysis by Application
6.1 World Paclitaxel Injection (Albumin-bound) Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Lung Cancer
6.2.2 Breast Cancer
6.2.3 Pancreatic Cancer
6.2.4 Other
6.3 Market Segment by Application
6.3.1 World Paclitaxel Injection (Albumin-bound) Production by Application (2018-2029)
6.3.2 World Paclitaxel Injection (Albumin-bound) Production Value by Application (2018-2029)
6.3.3 World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2029)

7 Company Profiles
7.1 Luye Pharma Group
7.1.1 Luye Pharma Group Details
7.1.2 Luye Pharma Group Major Business
7.1.3 Luye Pharma Group Paclitaxel Injection (Albumin-bound) Product and Services
7.1.4 Luye Pharma Group Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Luye Pharma Group Recent Developments/Updates
7.1.6 Luye Pharma Group Competitive Strengths & Weaknesses
7.2 CSPC Pharmaceutical Group
7.2.1 CSPC Pharmaceutical Group Details
7.2.2 CSPC Pharmaceutical Group Major Business
7.2.3 CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Product and Services
7.2.4 CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 CSPC Pharmaceutical Group Recent Developments/Updates
7.2.6 CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
7.3 Jiangsu Hengrui Pharmaceuticals
7.3.1 Jiangsu Hengrui Pharmaceuticals Details
7.3.2 Jiangsu Hengrui Pharmaceuticals Major Business
7.3.3 Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Product and Services
7.3.4 Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
7.3.6 Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Celgene
7.4.1 Celgene Details
7.4.2 Celgene Major Business
7.4.3 Celgene Paclitaxel Injection (Albumin-bound) Product and Services
7.4.4 Celgene Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Celgene Recent Developments/Updates
7.4.6 Celgene Competitive Strengths & Weaknesses
7.5 Teva
7.5.1 Teva Details
7.5.2 Teva Major Business
7.5.3 Teva Paclitaxel Injection (Albumin-bound) Product and Services
7.5.4 Teva Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Teva Recent Developments/Updates
7.5.6 Teva Competitive Strengths & Weaknesses
7.6 Qilu Pharmaceutical (Hainan)
7.6.1 Qilu Pharmaceutical (Hainan) Details
7.6.2 Qilu Pharmaceutical (Hainan) Major Business
7.6.3 Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Product and Services
7.6.4 Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Qilu Pharmaceutical (Hainan) Recent Developments/Updates
7.6.6 Qilu Pharmaceutical (Hainan) Competitive Strengths & Weaknesses
7.7 Zhejiang Hisun Pharmaceutical
7.7.1 Zhejiang Hisun Pharmaceutical Details
7.7.2 Zhejiang Hisun Pharmaceutical Major Business
7.7.3 Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Product and Services
7.7.4 Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Zhejiang Hisun Pharmaceutical Recent Developments/Updates
7.7.6 Zhejiang Hisun Pharmaceutical Competitive Strengths & Weaknesses

8 Industry Chain Analysis
8.1 Paclitaxel Injection (Albumin-bound) Industry Chain
8.2 Paclitaxel Injection (Albumin-bound) Upstream Analysis
8.2.1 Paclitaxel Injection (Albumin-bound) Core Raw Materials
8.2.2 Main Manufacturers of Paclitaxel Injection (Albumin-bound) Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Paclitaxel Injection (Albumin-bound) Production Mode
8.6 Paclitaxel Injection (Albumin-bound) Procurement Model
8.7 Paclitaxel Injection (Albumin-bound) Industry Sales Model and Sales Channels
8.7.1 Paclitaxel Injection (Albumin-bound) Sales Model
8.7.2 Paclitaxel Injection (Albumin-bound) Typical Customers

9 Research Findings and Conclusion

10 Appendix
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2018-2023) & (USD Million)
Table 3. World Paclitaxel Injection (Albumin-bound) Production Value by Region (2024-2029) & (USD Million)
Table 4. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2018-2023)
Table 5. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2024-2029)
Table 6. World Paclitaxel Injection (Albumin-bound) Production by Region (2018-2023) & (K Units)
Table 7. World Paclitaxel Injection (Albumin-bound) Production by Region (2024-2029) & (K Units)
Table 8. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2018-2023)
Table 9. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2024-2029)
Table 10. World Paclitaxel Injection (Albumin-bound) Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Paclitaxel Injection (Albumin-bound) Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Paclitaxel Injection (Albumin-bound) Major Market Trends
Table 13. World Paclitaxel Injection (Albumin-bound) Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Paclitaxel Injection (Albumin-bound) Consumption by Region (2018-2023) & (K Units)
Table 15. World Paclitaxel Injection (Albumin-bound) Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Paclitaxel Injection (Albumin-bound) Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Paclitaxel Injection (Albumin-bound) Producers in 2022
Table 18. World Paclitaxel Injection (Albumin-bound) Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Paclitaxel Injection (Albumin-bound) Producers in 2022
Table 20. World Paclitaxel Injection (Albumin-bound) Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Paclitaxel Injection (Albumin-bound) Company Evaluation Quadrant
Table 22. World Paclitaxel Injection (Albumin-bound) Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Paclitaxel Injection (Albumin-bound) Production Site of Key Manufacturer
Table 24. Paclitaxel Injection (Albumin-bound) Market: Company Product Type Footprint
Table 25. Paclitaxel Injection (Albumin-bound) Market: Company Product Application Footprint
Table 26. Paclitaxel Injection (Albumin-bound) Competitive Factors
Table 27. Paclitaxel Injection (Albumin-bound) New Entrant and Capacity Expansion Plans
Table 28. Paclitaxel Injection (Albumin-bound) Mergers & Acquisitions Activity
Table 29. United States VS China Paclitaxel Injection (Albumin-bound) Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Paclitaxel Injection (Albumin-bound) Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Paclitaxel Injection (Albumin-bound) Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 37. China Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 42. Rest of World Based Paclitaxel Injection (Albumin-bound) Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share (2018-2023)
Table 47. World Paclitaxel Injection (Albumin-bound) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Paclitaxel Injection (Albumin-bound) Production by Type (2018-2023) & (K Units)
Table 49. World Paclitaxel Injection (Albumin-bound) Production by Type (2024-2029) & (K Units)
Table 50. World Paclitaxel Injection (Albumin-bound) Production Value by Type (2018-2023) & (USD Million)
Table 51. World Paclitaxel Injection (Albumin-bound) Production Value by Type (2024-2029) & (USD Million)
Table 52. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Paclitaxel Injection (Albumin-bound) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Paclitaxel Injection (Albumin-bound) Production by Application (2018-2023) & (K Units)
Table 56. World Paclitaxel Injection (Albumin-bound) Production by Application (2024-2029) & (K Units)
Table 57. World Paclitaxel Injection (Albumin-bound) Production Value by Application (2018-2023) & (USD Million)
Table 58. World Paclitaxel Injection (Albumin-bound) Production Value by Application (2024-2029) & (USD Million)
Table 59. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Luye Pharma Group Basic Information, Manufacturing Base and Competitors
Table 62. Luye Pharma Group Major Business
Table 63. Luye Pharma Group Paclitaxel Injection (Albumin-bound) Product and Services
Table 64. Luye Pharma Group Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Luye Pharma Group Recent Developments/Updates
Table 66. Luye Pharma Group Competitive Strengths & Weaknesses
Table 67. CSPC Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 68. CSPC Pharmaceutical Group Major Business
Table 69. CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Product and Services
Table 70. CSPC Pharmaceutical Group Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. CSPC Pharmaceutical Group Recent Developments/Updates
Table 72. CSPC Pharmaceutical Group Competitive Strengths & Weaknesses
Table 73. Jiangsu Hengrui Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 74. Jiangsu Hengrui Pharmaceuticals Major Business
Table 75. Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Product and Services
Table 76. Jiangsu Hengrui Pharmaceuticals Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Jiangsu Hengrui Pharmaceuticals Recent Developments/Updates
Table 78. Jiangsu Hengrui Pharmaceuticals Competitive Strengths & Weaknesses
Table 79. Celgene Basic Information, Manufacturing Base and Competitors
Table 80. Celgene Major Business
Table 81. Celgene Paclitaxel Injection (Albumin-bound) Product and Services
Table 82. Celgene Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Celgene Recent Developments/Updates
Table 84. Celgene Competitive Strengths & Weaknesses
Table 85. Teva Basic Information, Manufacturing Base and Competitors
Table 86. Teva Major Business
Table 87. Teva Paclitaxel Injection (Albumin-bound) Product and Services
Table 88. Teva Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Teva Recent Developments/Updates
Table 90. Teva Competitive Strengths & Weaknesses
Table 91. Qilu Pharmaceutical (Hainan) Basic Information, Manufacturing Base and Competitors
Table 92. Qilu Pharmaceutical (Hainan) Major Business
Table 93. Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Product and Services
Table 94. Qilu Pharmaceutical (Hainan) Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Qilu Pharmaceutical (Hainan) Recent Developments/Updates
Table 96. Zhejiang Hisun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 97. Zhejiang Hisun Pharmaceutical Major Business
Table 98. Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Product and Services
Table 99. Zhejiang Hisun Pharmaceutical Paclitaxel Injection (Albumin-bound) Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 100. Global Key Players of Paclitaxel Injection (Albumin-bound) Upstream (Raw Materials)
Table 101. Paclitaxel Injection (Albumin-bound) Typical Customers
Table 102. Paclitaxel Injection (Albumin-bound) Typical Distributors
List of Figure
Figure 1. Paclitaxel Injection (Albumin-bound) Picture
Figure 2. World Paclitaxel Injection (Albumin-bound) Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Paclitaxel Injection (Albumin-bound) Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 5. World Paclitaxel Injection (Albumin-bound) Average Price (2018-2029) & (US$/Unit)
Figure 6. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Region (2018-2029)
Figure 7. World Paclitaxel Injection (Albumin-bound) Production Market Share by Region (2018-2029)
Figure 8. North America Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 9. Europe Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 10. China Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 11. Japan Paclitaxel Injection (Albumin-bound) Production (2018-2029) & (K Units)
Figure 12. Paclitaxel Injection (Albumin-bound) Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 15. World Paclitaxel Injection (Albumin-bound) Consumption Market Share by Region (2018-2029)
Figure 16. United States Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 17. China Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 18. Europe Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 19. Japan Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 20. South Korea Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 22. India Paclitaxel Injection (Albumin-bound) Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Paclitaxel Injection (Albumin-bound) by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Paclitaxel Injection (Albumin-bound) Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Paclitaxel Injection (Albumin-bound) Markets in 2022
Figure 26. United States VS China: Paclitaxel Injection (Albumin-bound) Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Paclitaxel Injection (Albumin-bound) Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Paclitaxel Injection (Albumin-bound) Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 30. China Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Paclitaxel Injection (Albumin-bound) Production Market Share 2022
Figure 32. World Paclitaxel Injection (Albumin-bound) Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Type in 2022
Figure 34. Original Drug
Figure 35. Generic Drug
Figure 36. World Paclitaxel Injection (Albumin-bound) Production Market Share by Type (2018-2029)
Figure 37. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Type (2018-2029)
Figure 38. World Paclitaxel Injection (Albumin-bound) Average Price by Type (2018-2029) & (US$/Unit)
Figure 39. World Paclitaxel Injection (Albumin-bound) Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 40. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Application in 2022
Figure 41. Lung Cancer
Figure 42. Breast Cancer
Figure 43. Pancreatic Cancer
Figure 44. Other
Figure 45. World Paclitaxel Injection (Albumin-bound) Production Market Share by Application (2018-2029)
Figure 46. World Paclitaxel Injection (Albumin-bound) Production Value Market Share by Application (2018-2029)
Figure 47. World Paclitaxel Injection (Albumin-bound) Average Price by Application (2018-2029) & (US$/Unit)
Figure 48. Paclitaxel Injection (Albumin-bound) Industry Chain
Figure 49. Paclitaxel Injection (Albumin-bound) Procurement Model
Figure 50. Paclitaxel Injection (Albumin-bound) Sales Model
Figure 51. Paclitaxel Injection (Albumin-bound) Sales Channels, Direct Sales, and Distribution
Figure 52. Methodology
Figure 53. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

jiaGou

Add To Cart

gouMai

Buy Now